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RESIDENT AND FACILITY-LEVEL CORRELATIONS OF LONG-TERM OPIOID USE IN 
UNITED STATES NURSING HOMES 
 
Jacob N. Hunnicutt, MPH1; Christine Ulbricht, PhD1; Anne Hume, PharmD2; Kate Lapane, PhD1 
1University of Massachusetts Medical School; 2University of Rhode Island, Kingston, RI 
 
Background: There is limited information on the prevalence and multilevel risk factors of long-
term opioid use in older nursing home residents despite their high burden of pain and 
vulnerability to adverse drug events. 
 
Objectives: To estimate the prevalence and correlates of long-term opioid use in United States 
(US) nursing homes. 
 
Methods: We used comprehensive administrative/claims data (Minimum Data Set 3.0; 
Medicare Part D) from 2012 to conduct a cross-sectional study of 369,180 long-stay nursing 
home residents who were Medicare beneficiaries, ≥65 years old, and had no cancer. Resident 
factors of interest included demographics and physical/cognitive impairment, and facility factors 
included US census region and structural characteristics (eg, bed size, ownership). Long-term 
opioid use was defined as ≥90 cumulative days of opioid use during a 120 day observation 
window - defined using fill dates and days’. Modified Poisson models were used to estimate 
adjusted prevalence ratios (aPR) and 95% confidence intervals (CI) between resident/ facility-
level characteristics and long-term opioid use. 
 
Results: Nearly one third of long-stay residents used any opioid, with 14.5% using opioids long-
term. Among long-term users, 35.3% received a long-acting opioid, with 17.1% receiving high 
(≥90 mg/day oral morphine equivalents) daily doses. Hydrocodone (49.0%), tramadol (31.3%), 
and fentanyl (24.8%) were most commonly used. The prevalence of long-term use was higher in 
women (vs. men; aPR=1.20, 95% CI: 1.18-1.23) and those with no/mild cognitive impairment 
(vs. other; aPR=1.18, 95% CI: 1.16-1.20) or severe physical impairment (aPR=1.25; 95% CI: 
(1.22-1.27), and in government-owned nursing homes (vs. for-profit; aPR=1.10, 95% CI: 1.05-
1.16). Long-term use varied by region (10.6% [Northeast] to 17.7% [Midwest]) and across 
facilities (median: 13.3% interquartile range: 6.7%-21.3%). 
 
Conclusions: Long-term opioid use is substantially higher in nursing home residents than what 
has been previously reported in community-dwelling older adults. Further investigations of 
opioid safety in this frail population are needed. 
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